BioSpace News Archive

Policy

Pfizer-BioNTech Vaccine: African Deal, $34 Billion in Sales, and Efficacy Drop

Pfizer has reported several highlights regarding its mRNA COVID-19 vaccine. As the world deal with rising Delta variant cases, Pfizer-BioNTech is still arguing that a third booster shot will be likely.

July 29, 2021
·
3 min read
·
Mark Terry
Drug Development

Future of AstraZeneca’s Vaccine Business is Murky, But Seeks to Move Ahead with FDA Filing

AstraZeneca said in an earnings announcement on Thursday it will seek authorization for its COVID-19 vaccine in the U.S. sometime in the second half of this year.

July 29, 2021
·
3 min read
·
Brandon May
Drug Development

COVID News: EUA Expanded for Baricitinib, Emergent Starts to Manufacture J&J Vaccine Again and More

As COVID-19 infections continue to increase in the U.S., the FDA has expanded the EUA for Eli Lilly’s monoclonal antibody to include treatment with or without remdesivir.

July 29, 2021
·
3 min read
·
Alex Keown
Job Trends

Acknowledge These Pros & Cons Before You Hire an Independent Contractor

Discover the pros and cons before you hire an independent contractor (IC). These include freelancers, consultants, seasonal workers, and other temporary professionals.

July 29, 2021
·
4 min read
·
Lorenzo Soliman
Drug Development

Annovis Bio’s AD/PD Therapy Reduces Cytotoxic Cascade in Phase IIa Trials

Annovis Bio’s therapy for Alzheimer’s disease is fast-acting and has the potential for Alzheimer’s patients to significantly improve cognition and motor function, according to data presented at the Alzheimer’s Association International Conference® 2021 (AAIC®), held July 26th through 30th.

July 29, 2021
·
3 min read
·
Gail Dutton
Business

BioSpace Movers & Shakers, July 30, 2021

Biopharma and life science companies strengthen their leadership teams and boards with these Movers & Shakers.

July 29, 2021
·
9 min read
·
Alex Keown
Business

bluebird bio and National Resilience Ink Cell Therapy Strategic Alliance

bluebird bio and National Resilience signed a strategic alliance around cell therapies. As part of the deal, Resilience is buying bluebird’s manufacturing facility in Research Triangle Park, keeping more than 100 staffers.

July 29, 2021
·
2 min read
·
Mark Terry
BioForest

Research Roundup: Immune Memory Against COVID-19 and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

July 29, 2021
·
5 min read
·
Mark Terry
Career Advice

Counterproductive Career Advice That You Should Ignore

Getting job-hunting and career advice is hard, especially when you get it from those who have worked for decades. Some advice is still helpful today, like making a good impression, but others are considered counter-productive.

July 29, 2021
·
3 min read
·
Lorenzo Soliman
Business

Profiling the Risk-Benefit Analysis of COVID-19 Vaccines for Kids

The United States and other wealthy nations now stand at an important place in their COVID-19 vaccine campaigns. The question largely turns to vaccinating the remainder of the population – namely, those under 12 years.

July 29, 2021
·
5 min read
·
Heather McKenzie